Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME

Detalhes bibliográficos
Autor(a) principal: Santiago Silva, Matheus
Data de Publicação: 2022
Outros Autores: Steinhorst Calixto, Greyce Kelly, Lourenço, Felipe Rebello, Oliveira, Débora Cristina, Calixto, Leandro Augusto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/205007
Resumo: Thiazolidinedione, often shortened to TZD or glitazone, helps lower insulin resistance, which is the underlying problem for many people with type 2 diabetes. The two most known glitazones are pioglitazone (PGZ), with the brand name medicine Actos®, and rosiglitazone (RSG), which is Avandia®. This study presented a multivariate optimization in the microextraction procedure employing Fractional Factorial Design (FFD) combined with Desirability Function (DF) to determine TZD and metabolites in biological samples. Microextraction requires several parameters to be optimized; however, most of them still use univariate optimization. Finding optimum conditions by simple response is relatively simple, but the problems, in case of microextractions, are often more complex when it has more responses. For example, changing one factor that promotes one response may suppress the effect of the others. Thus, this multivariate optimization was applied for two bioanalytical methods for determination of TZD and metabolites, one by HPLC and other by CE, both using Hollow Fiber Liquid-Phase Microextraction (HF-LPME). The results establish the optimal values and elucidate how the factors that affect HF-LPME procedure perform in extraction efficiency for TZDs. Additionally, this study demonstrates that DF can be an important tool to optimize microextraction procedures.
id USP-31_2ffc54455abe0828de7a0a20b16e6ce2
oai_identifier_str oai:revistas.usp.br:article/205007
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPMEGlitazonesHollow-fiber liquid-phase microextractionFractional Factorial DesignDesirability FunctionThiazolidinedione, often shortened to TZD or glitazone, helps lower insulin resistance, which is the underlying problem for many people with type 2 diabetes. The two most known glitazones are pioglitazone (PGZ), with the brand name medicine Actos®, and rosiglitazone (RSG), which is Avandia®. This study presented a multivariate optimization in the microextraction procedure employing Fractional Factorial Design (FFD) combined with Desirability Function (DF) to determine TZD and metabolites in biological samples. Microextraction requires several parameters to be optimized; however, most of them still use univariate optimization. Finding optimum conditions by simple response is relatively simple, but the problems, in case of microextractions, are often more complex when it has more responses. For example, changing one factor that promotes one response may suppress the effect of the others. Thus, this multivariate optimization was applied for two bioanalytical methods for determination of TZD and metabolites, one by HPLC and other by CE, both using Hollow Fiber Liquid-Phase Microextraction (HF-LPME). The results establish the optimal values and elucidate how the factors that affect HF-LPME procedure perform in extraction efficiency for TZDs. Additionally, this study demonstrates that DF can be an important tool to optimize microextraction procedures.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-12-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20500710.1590/s2175-97902022e19049 Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/205007/194505Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantiago Silva, MatheusSteinhorst Calixto, Greyce Kelly Lourenço, Felipe Rebello Oliveira, Débora CristinaCalixto, Leandro Augusto2023-05-26T13:19:00Zoai:revistas.usp.br:article/205007Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-26T13:19Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
title Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
spellingShingle Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
Santiago Silva, Matheus
Glitazones
Hollow-fiber liquid-phase microextraction
Fractional Factorial Design
Desirability Function
title_short Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
title_full Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
title_fullStr Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
title_full_unstemmed Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
title_sort Desirability Function in analytical method development for determination of glitazones and metabolites employing HF-LPME
author Santiago Silva, Matheus
author_facet Santiago Silva, Matheus
Steinhorst Calixto, Greyce Kelly
Lourenço, Felipe Rebello
Oliveira, Débora Cristina
Calixto, Leandro Augusto
author_role author
author2 Steinhorst Calixto, Greyce Kelly
Lourenço, Felipe Rebello
Oliveira, Débora Cristina
Calixto, Leandro Augusto
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Santiago Silva, Matheus
Steinhorst Calixto, Greyce Kelly
Lourenço, Felipe Rebello
Oliveira, Débora Cristina
Calixto, Leandro Augusto
dc.subject.por.fl_str_mv Glitazones
Hollow-fiber liquid-phase microextraction
Fractional Factorial Design
Desirability Function
topic Glitazones
Hollow-fiber liquid-phase microextraction
Fractional Factorial Design
Desirability Function
description Thiazolidinedione, often shortened to TZD or glitazone, helps lower insulin resistance, which is the underlying problem for many people with type 2 diabetes. The two most known glitazones are pioglitazone (PGZ), with the brand name medicine Actos®, and rosiglitazone (RSG), which is Avandia®. This study presented a multivariate optimization in the microextraction procedure employing Fractional Factorial Design (FFD) combined with Desirability Function (DF) to determine TZD and metabolites in biological samples. Microextraction requires several parameters to be optimized; however, most of them still use univariate optimization. Finding optimum conditions by simple response is relatively simple, but the problems, in case of microextractions, are often more complex when it has more responses. For example, changing one factor that promotes one response may suppress the effect of the others. Thus, this multivariate optimization was applied for two bioanalytical methods for determination of TZD and metabolites, one by HPLC and other by CE, both using Hollow Fiber Liquid-Phase Microextraction (HF-LPME). The results establish the optimal values and elucidate how the factors that affect HF-LPME procedure perform in extraction efficiency for TZDs. Additionally, this study demonstrates that DF can be an important tool to optimize microextraction procedures.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-19
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205007
10.1590/s2175-97902022e19049
url https://www.revistas.usp.br/bjps/article/view/205007
identifier_str_mv 10.1590/s2175-97902022e19049
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205007/194505
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222916501045248